Figure 22.1. Average Number of Antihypertensive Agents Used to Try to Reach Blood Pressure Goal in Several Hypertension Trials.

Figure 22.1Average Number of Antihypertensive Agents Used to Try to Reach Blood Pressure Goal in Several Hypertension Trials

Bakris 2004; Dahlöf and others 2005.

Note: AASK = African American Study of Kidney Disease and Hypertension; ABCD = Appropriate Blood Pressure Control in Diabetes trial; ALLHAT = Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial; ASCOT-BPLA = Anglo-Scandinavian Cardiac Outcomes Trial–Blood Pressure Lowering Arm; HOT = Hypertension Optimal Treatment Study; IDNT = Irbesartan Diabetic Nephropathy Trial; MDRD = Modification of Diet in Renal Disease study; mmHg = millimeters of mercury, a unit of pressure; RENAAL = Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan study; SBP = systolic blood pressure; UKPDS = U.K. Prospective Diabetes Study.

From: Chapter 22, Management of Hypertension and Dyslipidemia for Primary Prevention of Cardiovascular Disease

Cover of Cardiovascular, Respiratory, and Related Disorders
Cardiovascular, Respiratory, and Related Disorders. 3rd edition.
Prabhakaran D, Anand S, Gaziano TA, et al., editors.
© 2017 International Bank for Reconstruction and Development / The World Bank.

This work is available under the Creative Commons Attribution 3.0 IGO license (CC BY 3.0 IGO) http://creativecommons.org/licenses/by/3.0/igo. Under the Creative Commons Attribution license, you are free to copy, distribute, transmit, and adapt this work, including for commercial purposes, under the following conditions:

Attribution—Please cite the work as follows: Patel, V., D. Chisholm., T. Dua, R. Laxminarayan, and M. E. Medina-Mora, editors. 2015. Mental, Neurological, and Substance Use Disorders. Disease Control Priorities, third edition, volume 4. Washington, DC: World Bank. doi:10.1596/978-1-4648-0426-7. License: Creative Commons Attribution CC BY 3.0 IGO

Translations—If you create a translation of this work, please add the following disclaimer along with the attribution: This translation was not created by The World Bank and should not be considered an official World Bank translation. The World Bank shall not be liable for any content or error in this translation.

Third-party content—The World Bank does not necessarily own each component of the content contained within the work. The World Bank therefore does not warrant that the use of any third-party-owned individual component or part contained in the work will not infringe on the rights of those third parties. The risk of claims resulting from such infringement rests solely with you. If you wish to re-use a component of the work, it is your responsibility to determine whether permission is needed for that re-use and to obtain permission from the copyright owner. Examples of components can include, but are not limited to, tables, figures, or images.

All queries on rights and licenses should be addressed to the Publishing and Knowledge Division, The World Bank, 1818 H Street NW, Washington, DC 20433, USA; fax: 202-522-2625; e-mail: gro.knabdlrow@sthgirbup.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.